Ann: VIRALEZE SPL7013 highly active in UK variant of coronavirus, page-71

First 71 Last

Share
Profile

Follow
col69

15,627 Posts.

5705

31/05/22

09:29

Post #: 61719067
Share

Originally posted by chrisnj ↑

IMO jackie overpromise but under deliver over and over with no any consequence.

@Biostock this makes me wonder if that will change this year particularly given the delays in the Dep trials not limited to the existing trials but also the fact that despite the claim (which was another load of BS) that they would be introducing 1 or 2 new candidates to the clinic annually made several years ago it appears the next candidate Dep Gemcitabine, which is the next in line, has hit some hurdles as they have been threatening to get this into the clinic for years. In the last quarterly this was their comment--

. In addition, DEP® gemcitabine is expected to commence its first in human study soon, with preclinical work being
finalised.
"soon" and "being finalised" will go down in SPL's history book as iconic words for all the wrong reasons.

I'm tipping that unless some serious action happens prior to this years AGM then there will be serious consequences for management

Expand

Yes @chrisnj we were told way back at the CR for $1.50 in 2020 that the development of the DEP® indications would be "accelerated" (JF's words) ? Once again I think the crew at HQ need a thesaurus because since this placement in 2020 I wouldn't call the progress of the DEP® assets accelerated - just sayin'

SPL Price at posting: 74.5¢ Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

BPM

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

HVN

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

PAR

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

88E

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

CXU

Cauldron discovers shallow uranium up to 2km at WA's Yanrey

There are more pages in this discussion • 8 more messages in this thread...

First 71 Last

Add SPL (ASX) to my watchlist

(20min delay)
Last 9.8¢		Change 0.001(1.03%)		Mkt cap ! $40.90M

Open	High	Low	Value	Volume
9.9¢	10.5¢	9.8¢	$13.05K	130.9K

Buyers (Bids)

No.	Vol.	Price($)
2	46826	9.8¢

Sellers (Offers)

Price($)	Vol.	No.
10.0¢	69981	3

View Market Depth

No.	Vol.	Price($)
2	46826	0.098
4	865495	0.097
1	50000	0.096
3	176316	0.095
3	150000	0.094

Price($)	Vol.	No.
0.100	69981	3
0.105	90878	3
0.110	210058	7
0.115	122327	4
0.120	59907	7

Last trade - 13.20pm 18/09/2024 (20 minute delay)

SPL (ASX) Chart

Ann: VIRALEZE SPL7013 highly active in UK variant of coronavirus, page-71

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

Cauldron discovers shallow uranium up to 2km at WA's Yanrey

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: VIRALEZE SPL7013 highly active in UK variant of coronavirus, page-71

Top Stories

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

Cauldron discovers shallow uranium up to 2km at WA's Yanrey

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News